About
Peptide Synthesizers & Custom Synthesis
Areas of Focus
Categories
Contract ManufacturingBiotech
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
0
As Collaborator
2
Total Enrollment
737
By Phase
PHASE2: 1PHASE3: 1
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06582277Collaborator
Safety and Immunogenicity of Two Dose Levels of OVX836 Influenza Vaccine as a Booster on Participants Previously Administered With OVX836
PHASE2Completed
117 participants
Started: Oct 22, 2024 · Completed: Jun 2, 2025
NCT02547818Collaborator
Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease
PHASE3Completed
620 participants
Started: Sep 15, 2015 · Completed: Nov 18, 2020
Locations (1)
Headquarters
Menlo Park, CA, United States
Map
Loading map...